3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycythemia Vera
1
Myeloproliferative Disorders
1
Interventions
anlotinib
5
Cisplatin
5
Carboplatin
5
Immune Checkpoint Inhibitors
4
tislelizumab
3
sintilimab
3
lenvatinib
3
Oxaliplatin
3
Fluorouracil
3
Capecitabine
3
Bevacizumab
3
venetoclax
2
Rosuvastatin Calcium
2
Prednisone
2
Megestrol Acetate
2
Leucovorin
2
Gemcitabine
2
Drug Therapy
2
Dexmedetomidine
2
Dexamethasone
2
Aspirin
2
zanubrutinib
1
xiaojin wan
1
trastuzumab deruxtecan
1
trametinib
1
toripalimab
1
tocilizumab
1
testosterone 17 beta-cypionate
1
tenofovir alafenamide
1
telitacicept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Not yet recruiting
×
Phlebotomy
×
Clear all
NCT06290765
2025-07-31
PV
PharmaEssentia
Phase 4
Not yet recruiting
70 enrolled